Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hans Biomed's share price for the quarter that ended in Dec. 2023 was ₩14680. Hans Biomed's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 13 Mil. Therefore, Hans Biomed's market cap for the quarter that ended in Dec. 2023 was ₩190,649 Mil.
Hans Biomed's quarterly market cap
declined
from Jun. 2023 (₩235,586 Mil) to Sep. 2023 (₩207,570 Mil) and
declined
from Sep. 2023 (₩207,570 Mil) to Dec. 2023 (₩190,649 Mil).
Hans Biomed's annual market cap
declined
from Sep. 2021 (₩160,691 Mil) to Sep. 2022 (₩92,675 Mil) but then
increased
from Sep. 2022 (₩92,675 Mil) to Sep. 2023 (₩207,570 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hans Biomed's Enterprise Value for Today is ₩197,435 Mil.
Hans Biomed Market Cap Historical Data
The historical data trend for Hans Biomed's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hans Biomed's Market Cap
For the Medical Devices subindustry, Hans Biomed's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hans Biomed's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's Market Cap distribution charts can be found below:
* The bar in red indicates where Hans Biomed's Market Cap falls into.
Hans Biomed Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Hans Biomed's Market Cap for the fiscal year that ended in Sep. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hans Biomed (XKRX:042520) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hans Biomed Market Cap Related Terms
Thank you for viewing the detailed overview of Hans Biomed's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:042520 has been successfully added to your 